nodes	percent_of_prediction	percent_of_DWPC	metapath
Chenodeoxycholic acid—UGT2B7—Carbamazepine—epilepsy syndrome	0.158	0.289	CbGbCtD
Chenodeoxycholic acid—UGT2B7—Valproic Acid—epilepsy syndrome	0.0944	0.173	CbGbCtD
Chenodeoxycholic acid—CYP3A4—Oxcarbazepine—epilepsy syndrome	0.0258	0.0473	CbGbCtD
Chenodeoxycholic acid—CYP3A4—Trimethadione—epilepsy syndrome	0.024	0.044	CbGbCtD
Chenodeoxycholic acid—CYP3A4—Felbamate—epilepsy syndrome	0.024	0.044	CbGbCtD
Chenodeoxycholic acid—CYP3A4—Fosphenytoin—epilepsy syndrome	0.0226	0.0413	CbGbCtD
Chenodeoxycholic acid—CYP3A4—Clonazepam—epilepsy syndrome	0.0204	0.0374	CbGbCtD
Chenodeoxycholic acid—CYP3A4—Clobazam—epilepsy syndrome	0.0196	0.0358	CbGbCtD
Chenodeoxycholic acid—CYP3A4—Rufinamide—epilepsy syndrome	0.0167	0.0305	CbGbCtD
Chenodeoxycholic acid—CYP3A4—Carbamazepine—epilepsy syndrome	0.0162	0.0297	CbGbCtD
Chenodeoxycholic acid—NR1H4—skull—epilepsy syndrome	0.0158	0.38	CbGeAlD
Chenodeoxycholic acid—CYP3A4—Primidone—epilepsy syndrome	0.0152	0.0277	CbGbCtD
Chenodeoxycholic acid—CYP3A4—Phenytoin—epilepsy syndrome	0.0146	0.0266	CbGbCtD
Chenodeoxycholic acid—CYP3A4—Propofol—epilepsy syndrome	0.0136	0.0248	CbGbCtD
Chenodeoxycholic acid—CYP3A4—Phenobarbital—epilepsy syndrome	0.013	0.0237	CbGbCtD
Chenodeoxycholic acid—CYP3A4—Acetazolamide—epilepsy syndrome	0.013	0.0237	CbGbCtD
Chenodeoxycholic acid—CYP3A4—Midazolam—epilepsy syndrome	0.0128	0.0234	CbGbCtD
Chenodeoxycholic acid—CYP3A4—Diazepam—epilepsy syndrome	0.0123	0.0225	CbGbCtD
Chenodeoxycholic acid—CYP3A4—Zonisamide—epilepsy syndrome	0.012	0.022	CbGbCtD
Chenodeoxycholic acid—CYP27A1—forelimb—epilepsy syndrome	0.0111	0.267	CbGeAlD
Chenodeoxycholic acid—CYP3A4—Valproic Acid—epilepsy syndrome	0.0097	0.0177	CbGbCtD
Chenodeoxycholic acid—CYP3A4—Topiramate—epilepsy syndrome	0.00875	0.016	CbGbCtD
Chenodeoxycholic acid—Tauroursodeoxycholic acid—SLCO1A2—epilepsy syndrome	0.00349	0.592	CrCbGaD
Chenodeoxycholic acid—CYP27A1—forebrain—epilepsy syndrome	0.00251	0.0604	CbGeAlD
Chenodeoxycholic acid—CYP27A1—medulla oblongata—epilepsy syndrome	0.00181	0.0436	CbGeAlD
Chenodeoxycholic acid—CYP27A1—midbrain—epilepsy syndrome	0.00166	0.0399	CbGeAlD
Chenodeoxycholic acid—Ursodeoxycholic acid—SLCO1A2—epilepsy syndrome	0.00162	0.276	CrCbGaD
Chenodeoxycholic acid—CYP27A1—spinal cord—epilepsy syndrome	0.00162	0.0389	CbGeAlD
Chenodeoxycholic acid—CYP27A1—head—epilepsy syndrome	0.00144	0.0346	CbGeAlD
Chenodeoxycholic acid—CYP27A1—nervous system—epilepsy syndrome	0.00136	0.0328	CbGeAlD
Chenodeoxycholic acid—CYP27A1—central nervous system—epilepsy syndrome	0.00131	0.0316	CbGeAlD
Chenodeoxycholic acid—CYP27A1—cerebellum—epilepsy syndrome	0.00128	0.0309	CbGeAlD
Chenodeoxycholic acid—CYP27A1—brain—epilepsy syndrome	0.00104	0.0251	CbGeAlD
Chenodeoxycholic acid—Ursodeoxycholic acid—ABCC2—epilepsy syndrome	0.000777	0.132	CrCbGaD
Chenodeoxycholic acid—CYP3A4—nervous system—epilepsy syndrome	0.000329	0.00791	CbGeAlD
Chenodeoxycholic acid—CYP3A4—central nervous system—epilepsy syndrome	0.000317	0.00762	CbGeAlD
Chenodeoxycholic acid—CYP27A1—Metabolism—ALAD—epilepsy syndrome	0.000105	0.000991	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Gene Expression—EIF2B5—epilepsy syndrome	0.000104	0.000983	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—SLCO1A2—epilepsy syndrome	0.000101	0.000956	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—PFKL—epilepsy syndrome	0.000101	0.000956	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—CACNA2D2—epilepsy syndrome	0.000101	0.000956	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—KCNB1—epilepsy syndrome	0.000101	0.000956	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—SLC6A8—epilepsy syndrome	0.000101	0.000956	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism—CACNA1A—epilepsy syndrome	0.0001	0.000946	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism—ALDH7A1—epilepsy syndrome	0.0001	0.000946	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism of lipids and lipoproteins—CYP2C19—epilepsy syndrome	9.91e-05	0.000934	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism of lipids and lipoproteins—CYP11A1—epilepsy syndrome	9.85e-05	0.000929	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism—ST3GAL3—epilepsy syndrome	9.82e-05	0.000925	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Transmembrane transport of small molecules—ABCG2—epilepsy syndrome	9.67e-05	0.000912	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism—ADSL—epilepsy syndrome	9.62e-05	0.000907	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Generic Transcription Pathway—JUNB—epilepsy syndrome	9.49e-05	0.000895	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism—GLUL—epilepsy syndrome	9.43e-05	0.000889	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Gene Expression—TFAM—epilepsy syndrome	9.43e-05	0.000889	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Transmembrane transport of small molecules—ATP2A2—epilepsy syndrome	9.42e-05	0.000888	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—NEU1—epilepsy syndrome	9.27e-05	0.000874	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—UPB1—epilepsy syndrome	9.27e-05	0.000874	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—ATIC—epilepsy syndrome	9.27e-05	0.000874	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism—CACNA1D—epilepsy syndrome	9.26e-05	0.000873	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—epilepsy syndrome	9.08e-05	0.000856	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—HSD17B4—epilepsy syndrome	8.93e-05	0.000842	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism—TXNRD1—epilepsy syndrome	8.66e-05	0.000816	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—epilepsy syndrome	8.65e-05	0.000816	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—epilepsy syndrome	8.63e-05	0.000814	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—GBE1—epilepsy syndrome	8.62e-05	0.000813	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—PPP1R3C—epilepsy syndrome	8.62e-05	0.000813	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2C19—epilepsy syndrome	8.58e-05	0.000809	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP11A1—epilepsy syndrome	8.52e-05	0.000804	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Oxidation by Cytochrome P450—CYP2C19—epilepsy syndrome	8.46e-05	0.000798	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism of lipids and lipoproteins—BCHE—epilepsy syndrome	8.43e-05	0.000794	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Oxidation by Cytochrome P450—CYP11A1—epilepsy syndrome	8.41e-05	0.000793	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism—AQP1—epilepsy syndrome	8.41e-05	0.000793	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—CERS1—epilepsy syndrome	8.34e-05	0.000786	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—PDXK—epilepsy syndrome	8.34e-05	0.000786	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—GLUD1—epilepsy syndrome	8.34e-05	0.000786	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—L2HGDH—epilepsy syndrome	8.34e-05	0.000786	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—FAR1—epilepsy syndrome	8.34e-05	0.000786	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—ADK—epilepsy syndrome	8.34e-05	0.000786	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Gene Expression—SNRPE—epilepsy syndrome	8.14e-05	0.000767	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—ASAH1—epilepsy syndrome	8.1e-05	0.000764	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	8.07e-05	0.000761	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Transmembrane transport of small molecules—PLAT—epilepsy syndrome	8.01e-05	0.000755	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—STXBP1—epilepsy syndrome	7.88e-05	0.000743	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2D6—epilepsy syndrome	7.69e-05	0.000725	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—NT5E—epilepsy syndrome	7.68e-05	0.000724	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—ALAD—epilepsy syndrome	7.68e-05	0.000724	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Transmembrane transport of small molecules—SLC2A1—epilepsy syndrome	7.64e-05	0.000721	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—GAMT—epilepsy syndrome	7.63e-05	0.000719	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—PNPO—epilepsy syndrome	7.63e-05	0.000719	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—EPM2A—epilepsy syndrome	7.63e-05	0.000719	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—NHLRC1—epilepsy syndrome	7.63e-05	0.000719	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism—KCNJ11—epilepsy syndrome	7.6e-05	0.000717	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism—CHRM3—epilepsy syndrome	7.6e-05	0.000717	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Oxidation by Cytochrome P450—CYP2D6—epilepsy syndrome	7.59e-05	0.000716	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Generic Transcription Pathway—VDR—epilepsy syndrome	7.53e-05	0.00071	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—ALDH7A1—epilepsy syndrome	7.33e-05	0.000691	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—CACNA1A—epilepsy syndrome	7.33e-05	0.000691	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—ST3GAL3—epilepsy syndrome	7.17e-05	0.000676	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—QDPR—epilepsy syndrome	7.09e-05	0.000668	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—CA4—epilepsy syndrome	7.09e-05	0.000668	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	7.08e-05	0.000667	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Biological oxidations—POMC—epilepsy syndrome	7.07e-05	0.000666	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—ADSL—epilepsy syndrome	7.03e-05	0.000663	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Tryptophan metabolism—CAT—epilepsy syndrome	6.98e-05	0.000659	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Phase 1 - Functionalization of compounds—CYP2C19—epilepsy syndrome	6.95e-05	0.000656	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	6.94e-05	0.000654	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Phase 1 - Functionalization of compounds—CYP11A1—epilepsy syndrome	6.91e-05	0.000652	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—GLUL—epilepsy syndrome	6.89e-05	0.00065	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Generic Transcription Pathway—NR3C1—epilepsy syndrome	6.78e-05	0.000639	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—CACNA1D—epilepsy syndrome	6.76e-05	0.000638	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—COX3—epilepsy syndrome	6.67e-05	0.000628	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—TXNRD1—epilepsy syndrome	6.33e-05	0.000597	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—KCNB1—epilepsy syndrome	6.32e-05	0.000596	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—PFKL—epilepsy syndrome	6.32e-05	0.000596	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—CACNA2D2—epilepsy syndrome	6.32e-05	0.000596	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—SLCO1A2—epilepsy syndrome	6.32e-05	0.000596	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—SLC6A8—epilepsy syndrome	6.32e-05	0.000596	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	6.29e-05	0.000593	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Phase 1 - Functionalization of compounds—CYP2D6—epilepsy syndrome	6.24e-05	0.000588	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Transmembrane transport of small molecules—AVP—epilepsy syndrome	6.23e-05	0.000587	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism—ABCG2—epilepsy syndrome	6.2e-05	0.000584	CbGpPWpGaD
Chenodeoxycholic acid—Rash—Diazepam—epilepsy syndrome	6.16e-05	0.000205	CcSEcCtD
Chenodeoxycholic acid—Dermatitis—Diazepam—epilepsy syndrome	6.15e-05	0.000205	CcSEcCtD
Chenodeoxycholic acid—Visual impairment—Topiramate—epilepsy syndrome	6.14e-05	0.000205	CcSEcCtD
Chenodeoxycholic acid—NR1H4—Metabolism—AQP1—epilepsy syndrome	6.14e-05	0.000579	CbGpPWpGaD
Chenodeoxycholic acid—Myalgia—Pregabalin—epilepsy syndrome	6.13e-05	0.000204	CcSEcCtD
Chenodeoxycholic acid—Arthralgia—Pregabalin—epilepsy syndrome	6.13e-05	0.000204	CcSEcCtD
Chenodeoxycholic acid—Chest pain—Pregabalin—epilepsy syndrome	6.13e-05	0.000204	CcSEcCtD
Chenodeoxycholic acid—Ill-defined disorder—Gabapentin—epilepsy syndrome	6.12e-05	0.000204	CcSEcCtD
Chenodeoxycholic acid—Dizziness—Zonisamide—epilepsy syndrome	6.12e-05	0.000204	CcSEcCtD
Chenodeoxycholic acid—Headache—Diazepam—epilepsy syndrome	6.12e-05	0.000204	CcSEcCtD
Chenodeoxycholic acid—Diarrhoea—Clonazepam—epilepsy syndrome	6.1e-05	0.000204	CcSEcCtD
Chenodeoxycholic acid—Anaemia—Gabapentin—epilepsy syndrome	6.1e-05	0.000203	CcSEcCtD
Chenodeoxycholic acid—Unspecified disorder of skin and subcutaneous tissue—Pregabalin—epilepsy syndrome	6.08e-05	0.000203	CcSEcCtD
Chenodeoxycholic acid—Hypotension—Valproic Acid—epilepsy syndrome	6.07e-05	0.000202	CcSEcCtD
Chenodeoxycholic acid—Asthenia—Carbamazepine—epilepsy syndrome	6.07e-05	0.000202	CcSEcCtD
Chenodeoxycholic acid—Diarrhoea—Phenytoin—epilepsy syndrome	6.06e-05	0.000202	CcSEcCtD
Chenodeoxycholic acid—Discomfort—Pregabalin—epilepsy syndrome	6.05e-05	0.000202	CcSEcCtD
Chenodeoxycholic acid—Nausea—Fosphenytoin—epilepsy syndrome	6.05e-05	0.000202	CcSEcCtD
Chenodeoxycholic acid—CYP27A1—Metabolism—CYP2C19—epilepsy syndrome	6.04e-05	0.000569	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Transmembrane transport of small molecules—ABCB1—epilepsy syndrome	6.03e-05	0.000569	CbGpPWpGaD
Chenodeoxycholic acid—Diarrhoea—Oxcarbazepine—epilepsy syndrome	6.03e-05	0.000201	CcSEcCtD
Chenodeoxycholic acid—Angioedema—Gabapentin—epilepsy syndrome	6.03e-05	0.000201	CcSEcCtD
Chenodeoxycholic acid—Hypersensitivity—Lamotrigine—epilepsy syndrome	6.02e-05	0.000201	CcSEcCtD
Chenodeoxycholic acid—Vomiting—Felbamate—epilepsy syndrome	6.01e-05	0.0002	CcSEcCtD
Chenodeoxycholic acid—CYP27A1—Metabolism—CYP11A1—epilepsy syndrome	6e-05	0.000566	CbGpPWpGaD
Chenodeoxycholic acid—Dry mouth—Pregabalin—epilepsy syndrome	5.99e-05	0.0002	CcSEcCtD
Chenodeoxycholic acid—Pruritus—Carbamazepine—epilepsy syndrome	5.98e-05	0.0002	CcSEcCtD
Chenodeoxycholic acid—Rash—Felbamate—epilepsy syndrome	5.96e-05	0.000199	CcSEcCtD
Chenodeoxycholic acid—Eye disorder—Topiramate—epilepsy syndrome	5.96e-05	0.000199	CcSEcCtD
Chenodeoxycholic acid—CYP27A1—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	5.96e-05	0.000562	CbGpPWpGaD
Chenodeoxycholic acid—Dermatitis—Felbamate—epilepsy syndrome	5.96e-05	0.000199	CcSEcCtD
Chenodeoxycholic acid—Malaise—Gabapentin—epilepsy syndrome	5.95e-05	0.000198	CcSEcCtD
Chenodeoxycholic acid—Tinnitus—Topiramate—epilepsy syndrome	5.94e-05	0.000198	CcSEcCtD
Chenodeoxycholic acid—Vertigo—Gabapentin—epilepsy syndrome	5.93e-05	0.000198	CcSEcCtD
Chenodeoxycholic acid—Headache—Felbamate—epilepsy syndrome	5.92e-05	0.000198	CcSEcCtD
Chenodeoxycholic acid—Confusional state—Pregabalin—epilepsy syndrome	5.92e-05	0.000197	CcSEcCtD
Chenodeoxycholic acid—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	5.92e-05	0.000197	CcSEcCtD
Chenodeoxycholic acid—Cardiac disorder—Topiramate—epilepsy syndrome	5.92e-05	0.000197	CcSEcCtD
Chenodeoxycholic acid—Syncope—Gabapentin—epilepsy syndrome	5.92e-05	0.000197	CcSEcCtD
Chenodeoxycholic acid—Leukopenia—Gabapentin—epilepsy syndrome	5.91e-05	0.000197	CcSEcCtD
Chenodeoxycholic acid—NR1H4—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	5.9e-05	0.000556	CbGpPWpGaD
Chenodeoxycholic acid—Dizziness—Clonazepam—epilepsy syndrome	5.9e-05	0.000197	CcSEcCtD
Chenodeoxycholic acid—Nausea—Vigabatrin—epilepsy syndrome	5.89e-05	0.000197	CcSEcCtD
Chenodeoxycholic acid—Vomiting—Zonisamide—epilepsy syndrome	5.88e-05	0.000196	CcSEcCtD
Chenodeoxycholic acid—Insomnia—Valproic Acid—epilepsy syndrome	5.87e-05	0.000196	CcSEcCtD
Chenodeoxycholic acid—Oedema—Pregabalin—epilepsy syndrome	5.87e-05	0.000196	CcSEcCtD
Chenodeoxycholic acid—Asthenia—Lamotrigine—epilepsy syndrome	5.86e-05	0.000196	CcSEcCtD
Chenodeoxycholic acid—Dizziness—Phenytoin—epilepsy syndrome	5.86e-05	0.000195	CcSEcCtD
Chenodeoxycholic acid—Rash—Zonisamide—epilepsy syndrome	5.84e-05	0.000195	CcSEcCtD
Chenodeoxycholic acid—Infection—Pregabalin—epilepsy syndrome	5.83e-05	0.000195	CcSEcCtD
Chenodeoxycholic acid—Paraesthesia—Valproic Acid—epilepsy syndrome	5.83e-05	0.000194	CcSEcCtD
Chenodeoxycholic acid—Palpitations—Gabapentin—epilepsy syndrome	5.83e-05	0.000194	CcSEcCtD
Chenodeoxycholic acid—Dermatitis—Zonisamide—epilepsy syndrome	5.83e-05	0.000194	CcSEcCtD
Chenodeoxycholic acid—Dizziness—Oxcarbazepine—epilepsy syndrome	5.83e-05	0.000194	CcSEcCtD
Chenodeoxycholic acid—Nausea—Diazepam—epilepsy syndrome	5.8e-05	0.000194	CcSEcCtD
Chenodeoxycholic acid—Loss of consciousness—Gabapentin—epilepsy syndrome	5.8e-05	0.000193	CcSEcCtD
Chenodeoxycholic acid—Headache—Zonisamide—epilepsy syndrome	5.8e-05	0.000193	CcSEcCtD
Chenodeoxycholic acid—Dyspnoea—Valproic Acid—epilepsy syndrome	5.79e-05	0.000193	CcSEcCtD
Chenodeoxycholic acid—Diarrhoea—Carbamazepine—epilepsy syndrome	5.79e-05	0.000193	CcSEcCtD
Chenodeoxycholic acid—Angiopathy—Topiramate—epilepsy syndrome	5.78e-05	0.000193	CcSEcCtD
Chenodeoxycholic acid—Pruritus—Lamotrigine—epilepsy syndrome	5.78e-05	0.000193	CcSEcCtD
Chenodeoxycholic acid—UGT2B7—Metabolism—NEU1—epilepsy syndrome	5.78e-05	0.000545	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—UPB1—epilepsy syndrome	5.78e-05	0.000545	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—ATIC—epilepsy syndrome	5.78e-05	0.000545	CbGpPWpGaD
Chenodeoxycholic acid—Shock—Pregabalin—epilepsy syndrome	5.78e-05	0.000193	CcSEcCtD
Chenodeoxycholic acid—Somnolence—Valproic Acid—epilepsy syndrome	5.77e-05	0.000193	CcSEcCtD
Chenodeoxycholic acid—Immune system disorder—Topiramate—epilepsy syndrome	5.76e-05	0.000192	CcSEcCtD
Chenodeoxycholic acid—Nervous system disorder—Pregabalin—epilepsy syndrome	5.76e-05	0.000192	CcSEcCtD
Chenodeoxycholic acid—Cough—Gabapentin—epilepsy syndrome	5.76e-05	0.000192	CcSEcCtD
Chenodeoxycholic acid—Thrombocytopenia—Pregabalin—epilepsy syndrome	5.75e-05	0.000192	CcSEcCtD
Chenodeoxycholic acid—Mediastinal disorder—Topiramate—epilepsy syndrome	5.75e-05	0.000192	CcSEcCtD
Chenodeoxycholic acid—Tachycardia—Pregabalin—epilepsy syndrome	5.73e-05	0.000191	CcSEcCtD
Chenodeoxycholic acid—Chills—Topiramate—epilepsy syndrome	5.72e-05	0.000191	CcSEcCtD
Chenodeoxycholic acid—Dyspepsia—Valproic Acid—epilepsy syndrome	5.72e-05	0.000191	CcSEcCtD
Chenodeoxycholic acid—Convulsion—Gabapentin—epilepsy syndrome	5.72e-05	0.000191	CcSEcCtD
Chenodeoxycholic acid—Skin disorder—Pregabalin—epilepsy syndrome	5.7e-05	0.00019	CcSEcCtD
Chenodeoxycholic acid—Hypertension—Gabapentin—epilepsy syndrome	5.7e-05	0.00019	CcSEcCtD
Chenodeoxycholic acid—Hyperhidrosis—Pregabalin—epilepsy syndrome	5.68e-05	0.000189	CcSEcCtD
Chenodeoxycholic acid—NR1H4—Gene Expression—EIF2S1—epilepsy syndrome	5.68e-05	0.000535	CbGpPWpGaD
Chenodeoxycholic acid—Vomiting—Clonazepam—epilepsy syndrome	5.67e-05	0.000189	CcSEcCtD
Chenodeoxycholic acid—Decreased appetite—Valproic Acid—epilepsy syndrome	5.65e-05	0.000188	CcSEcCtD
Chenodeoxycholic acid—Alopecia—Topiramate—epilepsy syndrome	5.63e-05	0.000188	CcSEcCtD
Chenodeoxycholic acid—Vomiting—Phenytoin—epilepsy syndrome	5.63e-05	0.000188	CcSEcCtD
Chenodeoxycholic acid—Rash—Clonazepam—epilepsy syndrome	5.62e-05	0.000188	CcSEcCtD
Chenodeoxycholic acid—Dermatitis—Clonazepam—epilepsy syndrome	5.62e-05	0.000187	CcSEcCtD
Chenodeoxycholic acid—Chest pain—Gabapentin—epilepsy syndrome	5.62e-05	0.000187	CcSEcCtD
Chenodeoxycholic acid—Arthralgia—Gabapentin—epilepsy syndrome	5.62e-05	0.000187	CcSEcCtD
Chenodeoxycholic acid—Myalgia—Gabapentin—epilepsy syndrome	5.62e-05	0.000187	CcSEcCtD
Chenodeoxycholic acid—Nausea—Felbamate—epilepsy syndrome	5.62e-05	0.000187	CcSEcCtD
Chenodeoxycholic acid—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	5.61e-05	0.000187	CcSEcCtD
Chenodeoxycholic acid—Vomiting—Oxcarbazepine—epilepsy syndrome	5.6e-05	0.000187	CcSEcCtD
Chenodeoxycholic acid—Fatigue—Valproic Acid—epilepsy syndrome	5.6e-05	0.000187	CcSEcCtD
Chenodeoxycholic acid—Anorexia—Pregabalin—epilepsy syndrome	5.6e-05	0.000187	CcSEcCtD
Chenodeoxycholic acid—Dizziness—Carbamazepine—epilepsy syndrome	5.59e-05	0.000187	CcSEcCtD
Chenodeoxycholic acid—Diarrhoea—Lamotrigine—epilepsy syndrome	5.59e-05	0.000186	CcSEcCtD
Chenodeoxycholic acid—Headache—Clonazepam—epilepsy syndrome	5.59e-05	0.000186	CcSEcCtD
Chenodeoxycholic acid—Rash—Phenytoin—epilepsy syndrome	5.59e-05	0.000186	CcSEcCtD
Chenodeoxycholic acid—Dermatitis—Phenytoin—epilepsy syndrome	5.58e-05	0.000186	CcSEcCtD
Chenodeoxycholic acid—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—epilepsy syndrome	5.58e-05	0.000186	CcSEcCtD
Chenodeoxycholic acid—UGT2B7—Metabolism—HSD17B4—epilepsy syndrome	5.56e-05	0.000525	CbGpPWpGaD
Chenodeoxycholic acid—Rash—Oxcarbazepine—epilepsy syndrome	5.56e-05	0.000185	CcSEcCtD
Chenodeoxycholic acid—NR1H4—Metabolism—CHRM3—epilepsy syndrome	5.55e-05	0.000524	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—KCNJ11—epilepsy syndrome	5.55e-05	0.000524	CbGpPWpGaD
Chenodeoxycholic acid—Pain—Valproic Acid—epilepsy syndrome	5.55e-05	0.000185	CcSEcCtD
Chenodeoxycholic acid—Constipation—Valproic Acid—epilepsy syndrome	5.55e-05	0.000185	CcSEcCtD
Chenodeoxycholic acid—Dermatitis—Oxcarbazepine—epilepsy syndrome	5.55e-05	0.000185	CcSEcCtD
Chenodeoxycholic acid—Headache—Phenytoin—epilepsy syndrome	5.55e-05	0.000185	CcSEcCtD
Chenodeoxycholic acid—Malnutrition—Topiramate—epilepsy syndrome	5.55e-05	0.000185	CcSEcCtD
Chenodeoxycholic acid—Discomfort—Gabapentin—epilepsy syndrome	5.55e-05	0.000185	CcSEcCtD
Chenodeoxycholic acid—Headache—Oxcarbazepine—epilepsy syndrome	5.52e-05	0.000184	CcSEcCtD
Chenodeoxycholic acid—Nausea—Zonisamide—epilepsy syndrome	5.5e-05	0.000183	CcSEcCtD
Chenodeoxycholic acid—Dry mouth—Gabapentin—epilepsy syndrome	5.49e-05	0.000183	CcSEcCtD
Chenodeoxycholic acid—Hypotension—Pregabalin—epilepsy syndrome	5.49e-05	0.000183	CcSEcCtD
Chenodeoxycholic acid—NR1H4—Gene Expression—HSPB1—epilepsy syndrome	5.48e-05	0.000516	CbGpPWpGaD
Chenodeoxycholic acid—Flatulence—Topiramate—epilepsy syndrome	5.47e-05	0.000182	CcSEcCtD
Chenodeoxycholic acid—Tension—Topiramate—epilepsy syndrome	5.45e-05	0.000182	CcSEcCtD
Chenodeoxycholic acid—CYP27A1—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	5.43e-05	0.000512	CbGpPWpGaD
Chenodeoxycholic acid—Confusional state—Gabapentin—epilepsy syndrome	5.43e-05	0.000181	CcSEcCtD
Chenodeoxycholic acid—CYP27A1—Metabolism—CYP2D6—epilepsy syndrome	5.42e-05	0.000511	CbGpPWpGaD
Chenodeoxycholic acid—Dizziness—Lamotrigine—epilepsy syndrome	5.41e-05	0.00018	CcSEcCtD
Chenodeoxycholic acid—Nervousness—Topiramate—epilepsy syndrome	5.39e-05	0.00018	CcSEcCtD
Chenodeoxycholic acid—Oedema—Gabapentin—epilepsy syndrome	5.38e-05	0.00018	CcSEcCtD
Chenodeoxycholic acid—Vomiting—Carbamazepine—epilepsy syndrome	5.38e-05	0.000179	CcSEcCtD
Chenodeoxycholic acid—UGT2B7—Metabolism—PPP1R3C—epilepsy syndrome	5.37e-05	0.000507	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—GBE1—epilepsy syndrome	5.37e-05	0.000507	CbGpPWpGaD
Chenodeoxycholic acid—Back pain—Topiramate—epilepsy syndrome	5.37e-05	0.000179	CcSEcCtD
Chenodeoxycholic acid—Feeling abnormal—Valproic Acid—epilepsy syndrome	5.35e-05	0.000178	CcSEcCtD
Chenodeoxycholic acid—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	5.35e-05	0.000178	CcSEcCtD
Chenodeoxycholic acid—Infection—Gabapentin—epilepsy syndrome	5.35e-05	0.000178	CcSEcCtD
Chenodeoxycholic acid—Muscle spasms—Topiramate—epilepsy syndrome	5.34e-05	0.000178	CcSEcCtD
Chenodeoxycholic acid—Rash—Carbamazepine—epilepsy syndrome	5.33e-05	0.000178	CcSEcCtD
Chenodeoxycholic acid—Dermatitis—Carbamazepine—epilepsy syndrome	5.33e-05	0.000178	CcSEcCtD
Chenodeoxycholic acid—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	5.31e-05	0.000177	CcSEcCtD
Chenodeoxycholic acid—Insomnia—Pregabalin—epilepsy syndrome	5.31e-05	0.000177	CcSEcCtD
Chenodeoxycholic acid—Nausea—Clonazepam—epilepsy syndrome	5.3e-05	0.000177	CcSEcCtD
Chenodeoxycholic acid—Headache—Carbamazepine—epilepsy syndrome	5.3e-05	0.000177	CcSEcCtD
Chenodeoxycholic acid—Shock—Gabapentin—epilepsy syndrome	5.3e-05	0.000177	CcSEcCtD
Chenodeoxycholic acid—Nervous system disorder—Gabapentin—epilepsy syndrome	5.28e-05	0.000176	CcSEcCtD
Chenodeoxycholic acid—Paraesthesia—Pregabalin—epilepsy syndrome	5.27e-05	0.000176	CcSEcCtD
Chenodeoxycholic acid—Thrombocytopenia—Gabapentin—epilepsy syndrome	5.27e-05	0.000176	CcSEcCtD
Chenodeoxycholic acid—Nausea—Phenytoin—epilepsy syndrome	5.26e-05	0.000176	CcSEcCtD
Chenodeoxycholic acid—Tachycardia—Gabapentin—epilepsy syndrome	5.26e-05	0.000175	CcSEcCtD
Chenodeoxycholic acid—Dyspnoea—Pregabalin—epilepsy syndrome	5.24e-05	0.000175	CcSEcCtD
Chenodeoxycholic acid—Nausea—Oxcarbazepine—epilepsy syndrome	5.23e-05	0.000175	CcSEcCtD
Chenodeoxycholic acid—Skin disorder—Gabapentin—epilepsy syndrome	5.23e-05	0.000174	CcSEcCtD
Chenodeoxycholic acid—Somnolence—Pregabalin—epilepsy syndrome	5.22e-05	0.000174	CcSEcCtD
Chenodeoxycholic acid—Hyperhidrosis—Gabapentin—epilepsy syndrome	5.21e-05	0.000174	CcSEcCtD
Chenodeoxycholic acid—Vomiting—Lamotrigine—epilepsy syndrome	5.2e-05	0.000173	CcSEcCtD
Chenodeoxycholic acid—NR1H4—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	5.17e-05	0.000488	CbGpPWpGaD
Chenodeoxycholic acid—Urticaria—Valproic Acid—epilepsy syndrome	5.16e-05	0.000172	CcSEcCtD
Chenodeoxycholic acid—CYP27A1—Metabolism—ADRA2A—epilepsy syndrome	5.16e-05	0.000486	CbGpPWpGaD
Chenodeoxycholic acid—Rash—Lamotrigine—epilepsy syndrome	5.15e-05	0.000172	CcSEcCtD
Chenodeoxycholic acid—Ill-defined disorder—Topiramate—epilepsy syndrome	5.15e-05	0.000172	CcSEcCtD
Chenodeoxycholic acid—Dermatitis—Lamotrigine—epilepsy syndrome	5.15e-05	0.000172	CcSEcCtD
Chenodeoxycholic acid—CYP27A1—Metabolism—BCHE—epilepsy syndrome	5.13e-05	0.000484	CbGpPWpGaD
Chenodeoxycholic acid—Body temperature increased—Valproic Acid—epilepsy syndrome	5.13e-05	0.000171	CcSEcCtD
Chenodeoxycholic acid—Abdominal pain—Valproic Acid—epilepsy syndrome	5.13e-05	0.000171	CcSEcCtD
Chenodeoxycholic acid—Anorexia—Gabapentin—epilepsy syndrome	5.13e-05	0.000171	CcSEcCtD
Chenodeoxycholic acid—Anaemia—Topiramate—epilepsy syndrome	5.13e-05	0.000171	CcSEcCtD
Chenodeoxycholic acid—Headache—Lamotrigine—epilepsy syndrome	5.12e-05	0.000171	CcSEcCtD
Chenodeoxycholic acid—Decreased appetite—Pregabalin—epilepsy syndrome	5.1e-05	0.00017	CcSEcCtD
Chenodeoxycholic acid—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	5.07e-05	0.000169	CcSEcCtD
Chenodeoxycholic acid—NR1H4—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	5.07e-05	0.000478	CbGpPWpGaD
Chenodeoxycholic acid—Fatigue—Pregabalin—epilepsy syndrome	5.06e-05	0.000169	CcSEcCtD
Chenodeoxycholic acid—UGT2B7—Metabolism—ASAH1—epilepsy syndrome	5.05e-05	0.000476	CbGpPWpGaD
Chenodeoxycholic acid—Hypotension—Gabapentin—epilepsy syndrome	5.03e-05	0.000168	CcSEcCtD
Chenodeoxycholic acid—Nausea—Carbamazepine—epilepsy syndrome	5.02e-05	0.000168	CcSEcCtD
Chenodeoxycholic acid—Pain—Pregabalin—epilepsy syndrome	5.02e-05	0.000167	CcSEcCtD
Chenodeoxycholic acid—Constipation—Pregabalin—epilepsy syndrome	5.02e-05	0.000167	CcSEcCtD
Chenodeoxycholic acid—Malaise—Topiramate—epilepsy syndrome	5.01e-05	0.000167	CcSEcCtD
Chenodeoxycholic acid—Vertigo—Topiramate—epilepsy syndrome	4.99e-05	0.000166	CcSEcCtD
Chenodeoxycholic acid—Syncope—Topiramate—epilepsy syndrome	4.98e-05	0.000166	CcSEcCtD
Chenodeoxycholic acid—Leukopenia—Topiramate—epilepsy syndrome	4.97e-05	0.000166	CcSEcCtD
Chenodeoxycholic acid—UGT2B7—Metabolism—STXBP1—epilepsy syndrome	4.91e-05	0.000463	CbGpPWpGaD
Chenodeoxycholic acid—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	4.91e-05	0.000164	CcSEcCtD
Chenodeoxycholic acid—Palpitations—Topiramate—epilepsy syndrome	4.91e-05	0.000164	CcSEcCtD
Chenodeoxycholic acid—CYP27A1—Metabolism—SLC2A1—epilepsy syndrome	4.9e-05	0.000462	CbGpPWpGaD
Chenodeoxycholic acid—Loss of consciousness—Topiramate—epilepsy syndrome	4.88e-05	0.000163	CcSEcCtD
Chenodeoxycholic acid—Insomnia—Gabapentin—epilepsy syndrome	4.87e-05	0.000162	CcSEcCtD
Chenodeoxycholic acid—Nausea—Lamotrigine—epilepsy syndrome	4.86e-05	0.000162	CcSEcCtD
Chenodeoxycholic acid—CYP27A1—Metabolism—PLCB1—epilepsy syndrome	4.84e-05	0.000457	CbGpPWpGaD
Chenodeoxycholic acid—Cough—Topiramate—epilepsy syndrome	4.84e-05	0.000162	CcSEcCtD
Chenodeoxycholic acid—Feeling abnormal—Pregabalin—epilepsy syndrome	4.84e-05	0.000161	CcSEcCtD
Chenodeoxycholic acid—Paraesthesia—Gabapentin—epilepsy syndrome	4.83e-05	0.000161	CcSEcCtD
Chenodeoxycholic acid—CYP27A1—Metabolism—TH—epilepsy syndrome	4.83e-05	0.000455	CbGpPWpGaD
Chenodeoxycholic acid—Convulsion—Topiramate—epilepsy syndrome	4.81e-05	0.00016	CcSEcCtD
Chenodeoxycholic acid—Gastrointestinal pain—Pregabalin—epilepsy syndrome	4.8e-05	0.00016	CcSEcCtD
Chenodeoxycholic acid—Dyspnoea—Gabapentin—epilepsy syndrome	4.8e-05	0.00016	CcSEcCtD
Chenodeoxycholic acid—Hypertension—Topiramate—epilepsy syndrome	4.79e-05	0.00016	CcSEcCtD
Chenodeoxycholic acid—UGT2B7—Metabolism—NT5E—epilepsy syndrome	4.79e-05	0.000452	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—ALAD—epilepsy syndrome	4.79e-05	0.000452	CbGpPWpGaD
Chenodeoxycholic acid—Somnolence—Gabapentin—epilepsy syndrome	4.79e-05	0.00016	CcSEcCtD
Chenodeoxycholic acid—Hypersensitivity—Valproic Acid—epilepsy syndrome	4.79e-05	0.00016	CcSEcCtD
Chenodeoxycholic acid—CYP27A1—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	4.75e-05	0.000448	CbGpPWpGaD
Chenodeoxycholic acid—Dyspepsia—Gabapentin—epilepsy syndrome	4.74e-05	0.000158	CcSEcCtD
Chenodeoxycholic acid—Myalgia—Topiramate—epilepsy syndrome	4.73e-05	0.000158	CcSEcCtD
Chenodeoxycholic acid—Chest pain—Topiramate—epilepsy syndrome	4.73e-05	0.000158	CcSEcCtD
Chenodeoxycholic acid—Arthralgia—Topiramate—epilepsy syndrome	4.73e-05	0.000158	CcSEcCtD
Chenodeoxycholic acid—Unspecified disorder of skin and subcutaneous tissue—Topiramate—epilepsy syndrome	4.69e-05	0.000156	CcSEcCtD
Chenodeoxycholic acid—Decreased appetite—Gabapentin—epilepsy syndrome	4.68e-05	0.000156	CcSEcCtD
Chenodeoxycholic acid—Discomfort—Topiramate—epilepsy syndrome	4.67e-05	0.000156	CcSEcCtD
Chenodeoxycholic acid—Urticaria—Pregabalin—epilepsy syndrome	4.66e-05	0.000156	CcSEcCtD
Chenodeoxycholic acid—Asthenia—Valproic Acid—epilepsy syndrome	4.66e-05	0.000155	CcSEcCtD
Chenodeoxycholic acid—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	4.65e-05	0.000155	CcSEcCtD
Chenodeoxycholic acid—Fatigue—Gabapentin—epilepsy syndrome	4.64e-05	0.000155	CcSEcCtD
Chenodeoxycholic acid—Abdominal pain—Pregabalin—epilepsy syndrome	4.64e-05	0.000155	CcSEcCtD
Chenodeoxycholic acid—Body temperature increased—Pregabalin—epilepsy syndrome	4.64e-05	0.000155	CcSEcCtD
Chenodeoxycholic acid—Dry mouth—Topiramate—epilepsy syndrome	4.62e-05	0.000154	CcSEcCtD
Chenodeoxycholic acid—Pain—Gabapentin—epilepsy syndrome	4.6e-05	0.000154	CcSEcCtD
Chenodeoxycholic acid—Constipation—Gabapentin—epilepsy syndrome	4.6e-05	0.000154	CcSEcCtD
Chenodeoxycholic acid—Pruritus—Valproic Acid—epilepsy syndrome	4.6e-05	0.000153	CcSEcCtD
Chenodeoxycholic acid—NR1H4—Gene Expression—JUNB—epilepsy syndrome	4.57e-05	0.000431	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—CACNA1A—epilepsy syndrome	4.57e-05	0.000431	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—ALDH7A1—epilepsy syndrome	4.57e-05	0.000431	CbGpPWpGaD
Chenodeoxycholic acid—Confusional state—Topiramate—epilepsy syndrome	4.57e-05	0.000152	CcSEcCtD
Chenodeoxycholic acid—Oedema—Topiramate—epilepsy syndrome	4.53e-05	0.000151	CcSEcCtD
Chenodeoxycholic acid—NR1H4—Metabolism—ABCG2—epilepsy syndrome	4.53e-05	0.000427	CbGpPWpGaD
Chenodeoxycholic acid—Infection—Topiramate—epilepsy syndrome	4.5e-05	0.00015	CcSEcCtD
Chenodeoxycholic acid—UGT2B7—Metabolism—ST3GAL3—epilepsy syndrome	4.47e-05	0.000422	CbGpPWpGaD
Chenodeoxycholic acid—Shock—Topiramate—epilepsy syndrome	4.46e-05	0.000149	CcSEcCtD
Chenodeoxycholic acid—Diarrhoea—Valproic Acid—epilepsy syndrome	4.44e-05	0.000148	CcSEcCtD
Chenodeoxycholic acid—Nervous system disorder—Topiramate—epilepsy syndrome	4.44e-05	0.000148	CcSEcCtD
Chenodeoxycholic acid—Feeling abnormal—Gabapentin—epilepsy syndrome	4.44e-05	0.000148	CcSEcCtD
Chenodeoxycholic acid—Thrombocytopenia—Topiramate—epilepsy syndrome	4.44e-05	0.000148	CcSEcCtD
Chenodeoxycholic acid—Tachycardia—Topiramate—epilepsy syndrome	4.42e-05	0.000147	CcSEcCtD
Chenodeoxycholic acid—NR1H4—Metabolism—CYP2C19—epilepsy syndrome	4.41e-05	0.000416	CbGpPWpGaD
Chenodeoxycholic acid—Gastrointestinal pain—Gabapentin—epilepsy syndrome	4.4e-05	0.000147	CcSEcCtD
Chenodeoxycholic acid—Skin disorder—Topiramate—epilepsy syndrome	4.4e-05	0.000147	CcSEcCtD
Chenodeoxycholic acid—NR1H4—Metabolism—CYP11A1—epilepsy syndrome	4.39e-05	0.000414	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—ADSL—epilepsy syndrome	4.38e-05	0.000413	CbGpPWpGaD
Chenodeoxycholic acid—Hyperhidrosis—Topiramate—epilepsy syndrome	4.38e-05	0.000146	CcSEcCtD
Chenodeoxycholic acid—NR1H4—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	4.35e-05	0.000411	CbGpPWpGaD
Chenodeoxycholic acid—Hypersensitivity—Pregabalin—epilepsy syndrome	4.33e-05	0.000144	CcSEcCtD
Chenodeoxycholic acid—Anorexia—Topiramate—epilepsy syndrome	4.32e-05	0.000144	CcSEcCtD
Chenodeoxycholic acid—UGT2B7—Metabolism—GLUL—epilepsy syndrome	4.3e-05	0.000405	CbGpPWpGaD
Chenodeoxycholic acid—Dizziness—Valproic Acid—epilepsy syndrome	4.3e-05	0.000143	CcSEcCtD
Chenodeoxycholic acid—Urticaria—Gabapentin—epilepsy syndrome	4.28e-05	0.000143	CcSEcCtD
Chenodeoxycholic acid—Abdominal pain—Gabapentin—epilepsy syndrome	4.26e-05	0.000142	CcSEcCtD
Chenodeoxycholic acid—Body temperature increased—Gabapentin—epilepsy syndrome	4.26e-05	0.000142	CcSEcCtD
Chenodeoxycholic acid—Hypotension—Topiramate—epilepsy syndrome	4.23e-05	0.000141	CcSEcCtD
Chenodeoxycholic acid—UGT2B7—Metabolism—CACNA1D—epilepsy syndrome	4.22e-05	0.000398	CbGpPWpGaD
Chenodeoxycholic acid—Asthenia—Pregabalin—epilepsy syndrome	4.21e-05	0.00014	CcSEcCtD
Chenodeoxycholic acid—Pruritus—Pregabalin—epilepsy syndrome	4.15e-05	0.000139	CcSEcCtD
Chenodeoxycholic acid—Vomiting—Valproic Acid—epilepsy syndrome	4.13e-05	0.000138	CcSEcCtD
Chenodeoxycholic acid—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	4.13e-05	0.000138	CcSEcCtD
Chenodeoxycholic acid—Insomnia—Topiramate—epilepsy syndrome	4.1e-05	0.000137	CcSEcCtD
Chenodeoxycholic acid—Rash—Valproic Acid—epilepsy syndrome	4.1e-05	0.000137	CcSEcCtD
Chenodeoxycholic acid—Dermatitis—Valproic Acid—epilepsy syndrome	4.09e-05	0.000136	CcSEcCtD
Chenodeoxycholic acid—Headache—Valproic Acid—epilepsy syndrome	4.07e-05	0.000136	CcSEcCtD
Chenodeoxycholic acid—Paraesthesia—Topiramate—epilepsy syndrome	4.07e-05	0.000136	CcSEcCtD
Chenodeoxycholic acid—Dyspnoea—Topiramate—epilepsy syndrome	4.04e-05	0.000135	CcSEcCtD
Chenodeoxycholic acid—CYP27A1—Metabolism—HMOX1—epilepsy syndrome	4.03e-05	0.00038	CbGpPWpGaD
Chenodeoxycholic acid—Somnolence—Topiramate—epilepsy syndrome	4.03e-05	0.000134	CcSEcCtD
Chenodeoxycholic acid—Diarrhoea—Pregabalin—epilepsy syndrome	4.02e-05	0.000134	CcSEcCtD
Chenodeoxycholic acid—Dyspepsia—Topiramate—epilepsy syndrome	3.99e-05	0.000133	CcSEcCtD
Chenodeoxycholic acid—CYP27A1—Metabolism—CAT—epilepsy syndrome	3.98e-05	0.000375	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	3.97e-05	0.000374	CbGpPWpGaD
Chenodeoxycholic acid—Hypersensitivity—Gabapentin—epilepsy syndrome	3.97e-05	0.000132	CcSEcCtD
Chenodeoxycholic acid—NR1H4—Metabolism—CYP2D6—epilepsy syndrome	3.96e-05	0.000373	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—TXNRD1—epilepsy syndrome	3.94e-05	0.000372	CbGpPWpGaD
Chenodeoxycholic acid—Decreased appetite—Topiramate—epilepsy syndrome	3.94e-05	0.000131	CcSEcCtD
Chenodeoxycholic acid—Gastrointestinal disorder—Topiramate—epilepsy syndrome	3.91e-05	0.00013	CcSEcCtD
Chenodeoxycholic acid—Fatigue—Topiramate—epilepsy syndrome	3.91e-05	0.00013	CcSEcCtD
Chenodeoxycholic acid—Dizziness—Pregabalin—epilepsy syndrome	3.88e-05	0.000129	CcSEcCtD
Chenodeoxycholic acid—Pain—Topiramate—epilepsy syndrome	3.87e-05	0.000129	CcSEcCtD
Chenodeoxycholic acid—Constipation—Topiramate—epilepsy syndrome	3.87e-05	0.000129	CcSEcCtD
Chenodeoxycholic acid—CYP27A1—Metabolism—ABCB1—epilepsy syndrome	3.87e-05	0.000365	CbGpPWpGaD
Chenodeoxycholic acid—Asthenia—Gabapentin—epilepsy syndrome	3.86e-05	0.000129	CcSEcCtD
Chenodeoxycholic acid—Nausea—Valproic Acid—epilepsy syndrome	3.86e-05	0.000129	CcSEcCtD
Chenodeoxycholic acid—UGT2B7—Metabolism—AQP1—epilepsy syndrome	3.83e-05	0.000361	CbGpPWpGaD
Chenodeoxycholic acid—Pruritus—Gabapentin—epilepsy syndrome	3.81e-05	0.000127	CcSEcCtD
Chenodeoxycholic acid—NR1H4—Transmembrane transport of small molecules—ALB—epilepsy syndrome	3.77e-05	0.000356	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—epilepsy syndrome	3.77e-05	0.000355	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—ADRA2A—epilepsy syndrome	3.77e-05	0.000355	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—BCHE—epilepsy syndrome	3.75e-05	0.000354	CbGpPWpGaD
Chenodeoxycholic acid—Vomiting—Pregabalin—epilepsy syndrome	3.73e-05	0.000125	CcSEcCtD
Chenodeoxycholic acid—Feeling abnormal—Topiramate—epilepsy syndrome	3.73e-05	0.000124	CcSEcCtD
Chenodeoxycholic acid—Gastrointestinal pain—Topiramate—epilepsy syndrome	3.7e-05	0.000124	CcSEcCtD
Chenodeoxycholic acid—Rash—Pregabalin—epilepsy syndrome	3.7e-05	0.000123	CcSEcCtD
Chenodeoxycholic acid—Dermatitis—Pregabalin—epilepsy syndrome	3.7e-05	0.000123	CcSEcCtD
Chenodeoxycholic acid—CYP3A4—Biological oxidations—CYP2C19—epilepsy syndrome	3.69e-05	0.000348	CbGpPWpGaD
Chenodeoxycholic acid—Diarrhoea—Gabapentin—epilepsy syndrome	3.68e-05	0.000123	CcSEcCtD
Chenodeoxycholic acid—NR1H4—Gene Expression—SIRT1—epilepsy syndrome	3.68e-05	0.000347	CbGpPWpGaD
Chenodeoxycholic acid—Headache—Pregabalin—epilepsy syndrome	3.68e-05	0.000123	CcSEcCtD
Chenodeoxycholic acid—CYP3A4—Biological oxidations—CYP11A1—epilepsy syndrome	3.67e-05	0.000346	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metapathway biotransformation—CYP2C19—epilepsy syndrome	3.64e-05	0.000343	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Gene Expression—VDR—epilepsy syndrome	3.63e-05	0.000342	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metapathway biotransformation—CYP11A1—epilepsy syndrome	3.62e-05	0.000341	CbGpPWpGaD
Chenodeoxycholic acid—Urticaria—Topiramate—epilepsy syndrome	3.6e-05	0.00012	CcSEcCtD
Chenodeoxycholic acid—CYP27A1—Metabolism—GPX1—epilepsy syndrome	3.6e-05	0.000339	CbGpPWpGaD
Chenodeoxycholic acid—Abdominal pain—Topiramate—epilepsy syndrome	3.58e-05	0.000119	CcSEcCtD
Chenodeoxycholic acid—Body temperature increased—Topiramate—epilepsy syndrome	3.58e-05	0.000119	CcSEcCtD
Chenodeoxycholic acid—NR1H4—Metabolism—SLC2A1—epilepsy syndrome	3.58e-05	0.000338	CbGpPWpGaD
Chenodeoxycholic acid—Dizziness—Gabapentin—epilepsy syndrome	3.56e-05	0.000119	CcSEcCtD
Chenodeoxycholic acid—NR1H4—Metabolism—PLCB1—epilepsy syndrome	3.54e-05	0.000334	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—TH—epilepsy syndrome	3.53e-05	0.000333	CbGpPWpGaD
Chenodeoxycholic acid—Nausea—Pregabalin—epilepsy syndrome	3.49e-05	0.000116	CcSEcCtD
Chenodeoxycholic acid—NR1H4—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	3.47e-05	0.000327	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—KCNJ11—epilepsy syndrome	3.46e-05	0.000326	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—CHRM3—epilepsy syndrome	3.46e-05	0.000326	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Gene Expression—H2AFX—epilepsy syndrome	3.44e-05	0.000324	CbGpPWpGaD
Chenodeoxycholic acid—Vomiting—Gabapentin—epilepsy syndrome	3.42e-05	0.000114	CcSEcCtD
Chenodeoxycholic acid—Rash—Gabapentin—epilepsy syndrome	3.39e-05	0.000113	CcSEcCtD
Chenodeoxycholic acid—Dermatitis—Gabapentin—epilepsy syndrome	3.39e-05	0.000113	CcSEcCtD
Chenodeoxycholic acid—Headache—Gabapentin—epilepsy syndrome	3.37e-05	0.000112	CcSEcCtD
Chenodeoxycholic acid—Hypersensitivity—Topiramate—epilepsy syndrome	3.34e-05	0.000111	CcSEcCtD
Chenodeoxycholic acid—NR1H4—Gene Expression—YWHAZ—epilepsy syndrome	3.32e-05	0.000313	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Biological oxidations—CYP2D6—epilepsy syndrome	3.31e-05	0.000312	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metapathway biotransformation—CYP2D6—epilepsy syndrome	3.27e-05	0.000308	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Gene Expression—NR3C1—epilepsy syndrome	3.26e-05	0.000308	CbGpPWpGaD
Chenodeoxycholic acid—Asthenia—Topiramate—epilepsy syndrome	3.25e-05	0.000108	CcSEcCtD
Chenodeoxycholic acid—Pruritus—Topiramate—epilepsy syndrome	3.2e-05	0.000107	CcSEcCtD
Chenodeoxycholic acid—Nausea—Gabapentin—epilepsy syndrome	3.2e-05	0.000107	CcSEcCtD
Chenodeoxycholic acid—CYP27A1—Metabolism—AGT—epilepsy syndrome	3.15e-05	0.000297	CbGpPWpGaD
Chenodeoxycholic acid—Diarrhoea—Topiramate—epilepsy syndrome	3.1e-05	0.000103	CcSEcCtD
Chenodeoxycholic acid—CYP27A1—Metabolism—APOE—epilepsy syndrome	3.09e-05	0.000291	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Phase 1 - Functionalization of compounds—POMC—epilepsy syndrome	3.06e-05	0.000288	CbGpPWpGaD
Chenodeoxycholic acid—Dizziness—Topiramate—epilepsy syndrome	3e-05	9.99e-05	CcSEcCtD
Chenodeoxycholic acid—NR1H4—Metabolism—HMOX1—epilepsy syndrome	2.94e-05	0.000278	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—CAT—epilepsy syndrome	2.91e-05	0.000274	CbGpPWpGaD
Chenodeoxycholic acid—Vomiting—Topiramate—epilepsy syndrome	2.88e-05	9.6e-05	CcSEcCtD
Chenodeoxycholic acid—Rash—Topiramate—epilepsy syndrome	2.86e-05	9.52e-05	CcSEcCtD
Chenodeoxycholic acid—Dermatitis—Topiramate—epilepsy syndrome	2.85e-05	9.52e-05	CcSEcCtD
Chenodeoxycholic acid—Headache—Topiramate—epilepsy syndrome	2.84e-05	9.46e-05	CcSEcCtD
Chenodeoxycholic acid—NR1H4—Metabolism—ABCB1—epilepsy syndrome	2.83e-05	0.000266	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—ABCG2—epilepsy syndrome	2.82e-05	0.000266	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—CYP2C19—epilepsy syndrome	2.75e-05	0.000259	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—CYP11A1—epilepsy syndrome	2.73e-05	0.000258	CbGpPWpGaD
Chenodeoxycholic acid—Nausea—Topiramate—epilepsy syndrome	2.69e-05	8.97e-05	CcSEcCtD
Chenodeoxycholic acid—CYP27A1—Metabolism—POMC—epilepsy syndrome	2.65e-05	0.00025	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—GPX1—epilepsy syndrome	2.63e-05	0.000248	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—CA13—epilepsy syndrome	2.53e-05	0.000238	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—CYP2D6—epilepsy syndrome	2.47e-05	0.000233	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism—ALB—epilepsy syndrome	2.42e-05	0.000228	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—ADRA2A—epilepsy syndrome	2.35e-05	0.000221	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—BCHE—epilepsy syndrome	2.34e-05	0.000221	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—AGT—epilepsy syndrome	2.3e-05	0.000217	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—APOE—epilepsy syndrome	2.26e-05	0.000213	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—SLC2A1—epilepsy syndrome	2.23e-05	0.00021	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—PLCB1—epilepsy syndrome	2.21e-05	0.000208	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—TH—epilepsy syndrome	2.2e-05	0.000207	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism—PTGS2—epilepsy syndrome	2.12e-05	0.0002	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—POMC—epilepsy syndrome	1.94e-05	0.000183	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—PDXK—epilepsy syndrome	1.91e-05	0.000181	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—FAR1—epilepsy syndrome	1.91e-05	0.000181	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—L2HGDH—epilepsy syndrome	1.91e-05	0.000181	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—CERS1—epilepsy syndrome	1.91e-05	0.000181	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—GLUD1—epilepsy syndrome	1.91e-05	0.000181	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—ADK—epilepsy syndrome	1.91e-05	0.000181	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—HMOX1—epilepsy syndrome	1.84e-05	0.000173	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—CAT—epilepsy syndrome	1.81e-05	0.000171	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—ALB—epilepsy syndrome	1.77e-05	0.000167	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—ABCB1—epilepsy syndrome	1.76e-05	0.000166	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—GAMT—epilepsy syndrome	1.75e-05	0.000165	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—PNPO—epilepsy syndrome	1.75e-05	0.000165	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—EPM2A—epilepsy syndrome	1.75e-05	0.000165	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—NHLRC1—epilepsy syndrome	1.75e-05	0.000165	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—GPX1—epilepsy syndrome	1.64e-05	0.000154	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—CA4—epilepsy syndrome	1.63e-05	0.000154	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—QDPR—epilepsy syndrome	1.63e-05	0.000154	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Biological oxidations—POMC—epilepsy syndrome	1.62e-05	0.000153	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—PTGS2—epilepsy syndrome	1.55e-05	0.000146	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—COX3—epilepsy syndrome	1.53e-05	0.000144	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—CACNA2D2—epilepsy syndrome	1.45e-05	0.000137	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—PFKL—epilepsy syndrome	1.45e-05	0.000137	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—KCNB1—epilepsy syndrome	1.45e-05	0.000137	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—SLCO1A2—epilepsy syndrome	1.45e-05	0.000137	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—SLC6A8—epilepsy syndrome	1.45e-05	0.000137	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—AGT—epilepsy syndrome	1.44e-05	0.000135	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—APOE—epilepsy syndrome	1.41e-05	0.000133	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—NEU1—epilepsy syndrome	1.33e-05	0.000125	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—UPB1—epilepsy syndrome	1.33e-05	0.000125	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—ATIC—epilepsy syndrome	1.33e-05	0.000125	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—HSD17B4—epilepsy syndrome	1.28e-05	0.00012	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—GBE1—epilepsy syndrome	1.23e-05	0.000116	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—PPP1R3C—epilepsy syndrome	1.23e-05	0.000116	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—POMC—epilepsy syndrome	1.21e-05	0.000114	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—ASAH1—epilepsy syndrome	1.16e-05	0.000109	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—STXBP1—epilepsy syndrome	1.13e-05	0.000106	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—ALB—epilepsy syndrome	1.1e-05	0.000104	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—NT5E—epilepsy syndrome	1.1e-05	0.000104	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—ALAD—epilepsy syndrome	1.1e-05	0.000104	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism—AKT1—epilepsy syndrome	1.06e-05	0.0001	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—ALDH7A1—epilepsy syndrome	1.05e-05	9.89e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—CACNA1A—epilepsy syndrome	1.05e-05	9.89e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—ST3GAL3—epilepsy syndrome	1.03e-05	9.68e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—ADSL—epilepsy syndrome	1.01e-05	9.48e-05	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Gene Expression—AKT1—epilepsy syndrome	1e-05	9.43e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—GLUL—epilepsy syndrome	9.86e-06	9.3e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—CACNA1D—epilepsy syndrome	9.68e-06	9.13e-05	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—PTGS2—epilepsy syndrome	9.64e-06	9.09e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—TXNRD1—epilepsy syndrome	9.06e-06	8.54e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—AQP1—epilepsy syndrome	8.79e-06	8.29e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—KCNJ11—epilepsy syndrome	7.95e-06	7.5e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—CHRM3—epilepsy syndrome	7.95e-06	7.5e-05	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—AKT1—epilepsy syndrome	7.77e-06	7.33e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—ABCG2—epilepsy syndrome	6.48e-06	6.11e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—CYP2C19—epilepsy syndrome	6.32e-06	5.96e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—CYP11A1—epilepsy syndrome	6.28e-06	5.92e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—CYP2D6—epilepsy syndrome	5.67e-06	5.34e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—ADRA2A—epilepsy syndrome	5.39e-06	5.09e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—BCHE—epilepsy syndrome	5.37e-06	5.06e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—SLC2A1—epilepsy syndrome	5.12e-06	4.83e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—PLCB1—epilepsy syndrome	5.07e-06	4.78e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—TH—epilepsy syndrome	5.05e-06	4.76e-05	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—AKT1—epilepsy syndrome	4.84e-06	4.57e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—HMOX1—epilepsy syndrome	4.21e-06	3.97e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—CAT—epilepsy syndrome	4.16e-06	3.92e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—ABCB1—epilepsy syndrome	4.05e-06	3.81e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—GPX1—epilepsy syndrome	3.76e-06	3.55e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—AGT—epilepsy syndrome	3.3e-06	3.11e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—APOE—epilepsy syndrome	3.23e-06	3.05e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—POMC—epilepsy syndrome	2.78e-06	2.62e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—ALB—epilepsy syndrome	2.53e-06	2.39e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—PTGS2—epilepsy syndrome	2.21e-06	2.09e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—AKT1—epilepsy syndrome	1.11e-06	1.05e-05	CbGpPWpGaD
